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Introduction
Nowadays, single-use bioreactors are widely accepted in
pharmaceutical industry. This is based on shorter batch to
batch times, reduced cleaning effort and a significantly
lower risk of cross contaminations [1,2]. One large field of
the application of single-use bioreactors is the seed train
cultivation of mammalian cells [1]. The focus is further
extended to perform state of the art fed-batch production
processes in such bioreactors. In this study an industrial
proven CHO fed-batch process is established in different
single-use and reusable bioreactors.
Materials and methods
Cell line, medium and process strategy
For the fed-batch process the cell line CHO DG44 (Cellca,
Germany) secreting human IgG1 was used. SMD5 med-
ium (Cellca, Germany) was prepared for the seed train
and PM5 medium (Cellca, Germany) as a basal medium
for the fed-batch culture. The feeding procedure
comprised the addition of three different feeds (feed med-
ium A, feed medium B and concentrated glucose solution).
After a 3 day batch phase, the 14 day fed-batch phase
started. The automated discontinuous bolus feed of feed
media A and B was supplemented by the glucose feed
solution to keep the glucose concentration above 3 g/L.
Bioreactors
The process was initially developed in a 5 L stirred glass
bioreactor therefore the BIOSTAT® B with a UniVessel®
5 L was considered as a reference. Single-use bioreactors
involved in this study were the stirred tank reactor BIO-
STAT® STR 50 L with a CultiBag STR 50 L and the
rocking motion bioreactor BIOSTAT® RM 50 optical with
CultiBag RM 50 L.
Process transfer
The used bioreactors were characterized in terms of
process engineering [3]. Due to different agitation and
gassing principles present in the BIOSTAT® STR and
RM the kLa and mixing times were chosen as a scale-up
criteria. The process conditions were specified to meet a
kLa-value of > 7 h
-1 [4] and a mixing time of < 60 s [5].
Sampling procedure
A daily sampling procedure was performed before the
bolus feed. Metabolites like glucose and lactate were
analyzed by the Radiometer ABL800 basic (Radiometer,
Germany). Viable cell density (VCD) and viability were
determined by the Cedex HiRes (Roche Diagnostics,
Germany).
Results
The process transfer is considered successful, if compar-
able cellular proliferation activities and product titers
are obtained.
The initial viable cell density in all systems was 0.3 -
0.4 × 106 cells/mL. At the start of the fed-batch phase a
viable cell density of 4 - 5 × 106 cells/mL could be
achieved. As seen in Figure 1A the viable cell density
peak of 27 - 28 × 106 cells/mL was reached in all sys-
tems after 8 - 9 days. At the point of harvest after
17 days viable cell densities between 12 - 17 × 106 cells/
mL and viabilities of 57 - 82% were reached. The cell
broth was harvested for further downstream operations.
A well-controlled pH value is essential for a reproduci-
ble cell proliferation. As seen in Figure 1B exemplarily
shown for the BIOSTAT® STR 50 L small peaks occurred* Correspondence: sebastian.ruhl@sartorius-stedim.com
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due to the daily addition of feed medium B (pH 11). The
offline measured pCO2 trend shows a constant decrease
during the batch phase followed by an increase during the
fed-batch phase with a maximum value of 135 mmHg.
Shown in Figure 1D glucose concentration could be
kept above 3 g/L in the fed-batch phase. Lactate had a
peak accumulation of 0.9 g/L at the end of the batch
phase and remained at low value afterwards.
The product yield in all cultivations was comparable to
the reference systems and exceeded 8 g/L IgG (Figure 1C).
Conclusion
The high cell density CHO fed-batch process with
industry relevant titers was successfully transfer from a
reference bioreactor to a variety of single-use bioreactor
systems.
Figure 1 Process trends.
Table 1 Bioreactor Setup and Process Parameters
BIOSTAT® RM 50 L STR 50 L B 5 L
Gassing principle Overlay Ring Sparger
Sensors Single-use optical patches Reusable probes
Working volume [L] 25 50 5
Initial volume [L] 13 26 2.6
pH set point 7.15
pH control CO2 gassing
pO2 set point 60% sat.
pO2 control Multi stage cascade comprising N2, Air, O2 - gassing
Agitation [rpm] 30 @ 10° rocking angle 150 400
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The kL a and mixing time were suitable as a scale-up
criteria for systems with different agitation principles.
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